Baseline prevalence and emergence of protease inhibitor resistance mutations ...

250 主题	0 好友	0 积分

Rank: 1

电梯直达

楼主

发表于 2017-4-30 18:45:41 |显示全部楼层 |倒序浏览

5速递币

题名	Baseline prevalence and emergence of protease inhibitor resistance mutations following treatment in chronic HCV genotype-1-infected individuals.
作者	Nguyen LT1, Gray E, Dean J, Carr M, Connell J, De Gascun C, Nguyen LA, O'Leary A, Bergin C, Hall W, Norris S.
杂志	Antivir Ther. 2015;20(8):865-9. doi: 10.3851/IMP2964. Epub 2015 Apr 29.
年\|卷\|期	Antivir Ther. 2015;20(8):865-9. doi: 10.3851/IMP2964. Epub 2015 Apr 29.
页码	Antivir Ther. 2015;20(8):865-9. doi: 10.3851/IMP2964. Epub 2015 Apr 29.
链接	https://www.ncbi.nlm.nih.gov/pubmed/25920764